118 related articles for article (PubMed ID: 26923979)
1. [Adiponectin receptor-targeted therapy for lifestyle-related diseases].
Iwabu M; Yamauchi T; Okada-Iwabu M; Kadowaki T
Clin Calcium; 2016 Mar; 26(3):413-8. PubMed ID: 26923979
[TBL] [Abstract][Full Text] [Related]
2. Structure and function analysis of adiponectin receptors toward development of novel antidiabetic agents promoting healthy longevity.
Okada-Iwabu M; Iwabu M; Yamauchi T; Kadowaki T
Endocr J; 2018 Oct; 65(10):971-977. PubMed ID: 30282888
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin receptor as a key player in healthy longevity and obesity-related diseases.
Yamauchi T; Kadowaki T
Cell Metab; 2013 Feb; 17(2):185-96. PubMed ID: 23352188
[TBL] [Abstract][Full Text] [Related]
4. Perspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in Obesity.
Okada-Iwabu M; Iwabu M; Ueki K; Yamauchi T; Kadowaki T
Diabetes Metab J; 2015 Oct; 39(5):363-72. PubMed ID: 26566493
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin receptors: a review of their structure, function and how they work.
Yamauchi T; Iwabu M; Okada-Iwabu M; Kadowaki T
Best Pract Res Clin Endocrinol Metab; 2014 Jan; 28(1):15-23. PubMed ID: 24417942
[TBL] [Abstract][Full Text] [Related]
6. [Aging and homeostasis. Development of novel AdipoR-targeted drugs with exercise-mimicking and anti-aging properties.].
Okada-Iwabu M; Yamauchi T; Iwabu M; Kadowaki T
Clin Calcium; 2017; 27(7):975-981. PubMed ID: 28649104
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin/AdipoRs signaling as a key player in testicular aging and associated metabolic disorders.
Choubey M; Ranjan A; Krishna A
Vitam Horm; 2021; 115():611-634. PubMed ID: 33706964
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of signal transduction via adiponectin and adiponectin receptors.
Heiker JT; Kosel D; Beck-Sickinger AG
Biol Chem; 2010 Sep; 391(9):1005-18. PubMed ID: 20536390
[TBL] [Abstract][Full Text] [Related]
9. [Developing Exercise-mimicking Drugs toward Realization of Preemptive Medicine for Lifestyle-related Diseases.].
Iwabu M; Yamauchi T; Okada-Iwabu M; Kadowaki T
Clin Calcium; 2018; 28(1):73-80. PubMed ID: 29279429
[TBL] [Abstract][Full Text] [Related]
10. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
Yamauchi T; Kadowaki T
Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
[TBL] [Abstract][Full Text] [Related]
11. Orally active osteoanabolic agent GTDF binds to adiponectin receptors, with a preference for AdipoR1, induces adiponectin-associated signaling, and improves metabolic health in a rodent model of diabetes.
Singh AK; Joharapurkar AA; Khan MP; Mishra JS; Singh N; Yadav M; Hossain Z; Khan K; Kumar S; Dhanesha NA; Mishra DP; Maurya R; Sharma S; Jain MR; Trivedi AK; Godbole MM; Gayen JR; Chattopadhyay N; Sanyal S
Diabetes; 2014 Oct; 63(10):3530-44. PubMed ID: 24848063
[TBL] [Abstract][Full Text] [Related]
12. AdipoRs- a potential therapeutic target for fibrotic disorders.
Ma L; Li X; Bai Z; Lin X; Lin K
Expert Opin Ther Targets; 2019 Feb; 23(2):93-106. PubMed ID: 30569772
[No Abstract] [Full Text] [Related]
13. Regulation and function of adiponectin receptors in skeletal muscle.
Lustig Y; Hemi R; Kanety H
Vitam Horm; 2012; 90():95-123. PubMed ID: 23017713
[TBL] [Abstract][Full Text] [Related]
14. Dual-therapy strategy for modification of adiponectin receptor signaling in aging-associated chronic diseases.
Waragai M; Ho G; Takamatsu Y; Shimizu Y; Sugino H; Sugama S; Takenouchi T; Masliah E; Hashimoto M
Drug Discov Today; 2018 Jun; 23(6):1305-1311. PubMed ID: 29747002
[TBL] [Abstract][Full Text] [Related]
15. Relationship between adiponectin, obesity and insulin resistance.
Balsan GA; Vieira JL; Oliveira AM; Portal VL
Rev Assoc Med Bras (1992); 2015; 61(1):72-80. PubMed ID: 25909213
[TBL] [Abstract][Full Text] [Related]
16. Molecular targeting of obesity pathways in cancer.
Surmacz E; Otvos L
Horm Mol Biol Clin Investig; 2015 May; 22(2):53-62. PubMed ID: 25879324
[TBL] [Abstract][Full Text] [Related]
17. Drug development research for novel adiponectin receptor-targeted antidiabetic drugs contributing to healthy longevity.
Okada-Iwabu M; Iwabu M; Yamauchi T; Kadowaki T
Diabetol Int; 2019 Oct; 10(4):237-244. PubMed ID: 31592400
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin and adiponectin receptors.
Kadowaki T; Yamauchi T
Endocr Rev; 2005 May; 26(3):439-51. PubMed ID: 15897298
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a novel potent peptide agonist to adiponectin receptor 1.
Kim S; Lee Y; Kim JW; Son YJ; Ma MJ; Um JH; Kim ND; Min SH; Kim DI; Kim BB
PLoS One; 2018; 13(6):e0199256. PubMed ID: 29912982
[TBL] [Abstract][Full Text] [Related]
20. Role of adiponectin in obesity related gastrointestinal carcinogenesis.
Nagaraju GP; Aliya S; Alese OB
Cytokine Growth Factor Rev; 2015 Feb; 26(1):83-93. PubMed ID: 25007742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
